We provide you with 20 years of free, institutional-grade data for CARA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CARA. Explore the full financial landscape of CARA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Cara Therapeutics, Inc(NASDAQ:CARA) 
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target th...
Website: http://www.caratherapeutics.com
Founded: 2004
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CARA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.